Pfizer Inc. (NYSE:PFE) announced top-line results from a Phase 4 study (CrisADe CARE 1) which showed that crisaborole ointment, 2%, was well-tolerated in children aged …
Tag: PFE
Pfizer Inc (NYSE:PFE) said it has named former U.S. Food and Drug Administration Commissioner Scott Gottlieb to its board of directors, effective immediately. Gottlieb stepped down abruptly …
Pfizer Inc. (NYSE:PFE) said the U.S. Food and Drug Administration has approved its oncology biosimilar Zirabev for the treatment of five types of cancer. The …
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) said the FDA has granted Orphan Drug Designation for its lead product candidate ARCT-810 to treat ornithine transcarbamylase deficiency – …
Acasti Pharma Inc. (NASDAQ:ACST) loss for fiscal 2019 expanded from $21.5 million in the prior year to $51.6 million due to higher R&D costs for the TRILOGY Phase …
Min Wanli, the chief machine intelligence scientist at Alibaba Group Holding Ltd (NYSE:BABA) Cloud, has tendered his resignation after six years with the e-commerce giant to …
Ford Motor Company (NYSE:F) has finished a $1 billion renovation at its two plants on Chicago’s far South Side. The company’s oldest continuously producing plant …
Pfizer Inc. (NYSE:PFE) has received approval from the European Commission for its TALZENNA a breast cancer drug. This approval follows the medicine’s approval by the U.S. …
